Saturday, 31 October 2026European Markets

CROSSWOOD Stock Went Up By Over 29% In The Last 21 Sessions

Loading stream...

recently, the stock of the real estate company crosswood has seen a meteoric rise. in just 21 sessions, the stock almost reached the sky, with an increase of 29.34%, indicating a very bullish market sentiment. the company's stock jumped from eur8.35 to eur10.80, demonstrating strong performance in a cac 40 market that has otherwise remained relatively static. despite this impressive surge, it is still 38.29% below its 52-week peak of eur17.50, last traded at eur10.80.

crosswood's real estate prominence

the increase in crosswood's stock price coincides with the company's prominent position in the french real estate market. with the notable rise in property investments due to the global economic bounce back, investors could see value in crosswood's wide-ranging portfolio, which includes shops, offices, and residential properties.

earnings per share as a performance indicator

crosswood's financial performance exudes optimism as its earnings per share (eps) stand at eur0.57 over the past twelve months. at present, the market is valuing crosswood at eur18.95 per share, based on trailing twelve month price-to-earnings ratio which could signify market confidence in its capacity to generate profits.

stochastic oscillator indicates overselling

despite the recent upward trend in its stock prices, the stochastic oscillator indicates that crosswood is currently oversold. this could imply that the shares might be undervalued at present and a price rise could soon be on the horizon.

stock performance and moving averages

crosswood's stock performance is significantly outstripping its moving averages, exceeding both the 50-day average of eur8.98 and the 200-day average of eur8.83. this underlines a strong upward momentum in its price trajectory.

trading volume increase

with the increase in trading volume, where it reached 50, three times its usual volume of 12, it seems that crosswood is attracting more and more investor attention.

given these trends, it's critical for investors to keep a close eye on crosswood, as its stock has shown signs of volatility in the near future.

more news about crosswood (cros.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com